MedTrace Logo

Clinical Investigation of Bleeding Reduction Efficacy on Toothpaste Containing 1.05% Chitosan

NCT06955871 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2025-08-15

No results posted yet for this study

Summary

The purpose of this study is to assess the bleeding reduction efficacy of toothpaste containing 1.05% Chitosan compared to a regular fluoride toothpaste, and compared to a toothpaste containing 67% bicarbonate.

Conditions

  • Bleeding Gum
  • Gingivitis

Interventions

OTHER

Toothpaste containing 1.05% Chitosan

Toothpaste containing 1.05% Chitosan

OTHER

Silica-based NaF Toothpaste

Silica-based NaF Toothpaste

OTHER

Toothpaste with 67% bicarbonate

Toothpaste containing 67% Bicarbonate

Sponsors & Collaborators

  • Colgate Palmolive

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-29
Primary Completion
2025-06-04
Completion
2025-06-04

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06955871 on ClinicalTrials.gov